Masimo ROE 2007-2019 | MASI

Current and historical return on equity (ROE) values for Masimo (MASI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Masimo ROE for the three months ending June 30, 2019 was 17.82%.
Masimo ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.20B $1.04B 20.17%
2019-03-31 $0.20B $1.01B 21.23%
2018-12-31 $0.19B $0.97B 22.34%
2018-09-30 $0.14B $0.91B 17.22%
2018-06-30 $0.12B $0.83B 15.56%
2018-03-31 $0.12B $0.77B 16.32%
2017-12-31 $0.13B $0.72B 17.96%
2017-09-30 $0.36B $0.72B 54.81%
2017-06-30 $0.35B $0.71B 62.79%
2017-03-31 $0.34B $0.63B 73.77%
2016-12-31 $0.31B $0.56B 85.71%
2016-09-30 $0.11B $0.33B 37.54%
2016-06-30 $0.10B $0.30B 36.50%
2016-03-31 $0.09B $0.27B 32.85%
2015-12-31 $0.08B $0.28B 28.79%
2015-09-30 $0.08B $0.27B 27.00%
2015-06-30 $0.08B $0.28B 25.31%
2015-03-31 $0.07B $0.33B 22.98%
2014-12-31 $0.07B $0.31B 23.10%
2014-09-30 $0.06B $0.28B 19.03%
2014-06-30 $0.06B $0.32B 18.90%
2014-03-31 $0.07B $0.35B 20.22%
2013-12-31 $0.06B $0.33B 19.11%
2013-09-30 $0.06B $0.31B 21.99%
2013-06-30 $0.06B $0.29B 21.31%
2013-03-31 $0.06B $0.28B 21.61%
2012-12-31 $0.06B $0.28B 21.67%
2012-09-30 $0.06B $0.31B 21.25%
2012-06-30 $0.06B $0.30B 21.91%
2012-03-31 $0.06B $0.28B 21.87%
2011-12-31 $0.06B $0.28B 23.04%
2011-09-30 $0.07B $0.30B 24.88%
2011-06-30 $0.07B $0.28B 26.51%
2011-03-31 $0.06B $0.26B 26.69%
2010-12-31 $0.07B $0.23B 31.98%
2010-09-30 $0.07B $0.25B 29.19%
2010-06-30 $0.07B $0.23B 27.28%
2010-03-31 $0.07B $0.21B 26.17%
2009-12-31 $0.05B $0.29B 20.17%
2009-09-30 $0.04B $0.27B 15.51%
2009-06-30 $0.04B $0.25B 16.47%
2009-03-31 $0.04B $0.24B 16.78%
2008-12-31 $0.03B $0.22B 16.20%
2008-09-30 $0.04B $0.21B 24.41%
2008-06-30 $0.04B $0.19B 23.60%
2008-03-31 $0.03B $0.17B 22.56%
2007-12-31 $0.02B $0.15B 25.27%
2007-09-30 $0.02B $0.14B 28.04%
2007-06-30 $0.01B $0.08B 62.34%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.964B $0.858B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $109.454B 23.32
Intuitive Surgical (ISRG) United States $57.612B 50.39
Edwards Lifesciences (EW) United States $44.757B 43.56
IDEXX Laboratories (IDXX) United States $23.509B 58.98
Fresenius Medical Care AG KGaA (FMS) Germany $19.957B 13.22
Teleflex (TFX) United States $17.035B 36.16
Olympus (OCPNY) Japan $16.189B 121.13
SONOVA HOLDING (SONVY) Switzerland $14.665B 0.00
DexCom (DXCM) United States $14.456B 214.23
Hologic (HOLX) United States $13.317B 21.02
STERIS (STE) Ireland $12.870B 29.68
Sysmex ADR (SSMXY) Japan $12.420B 33.48
Varian Medical Systems (VAR) United States $9.773B 23.38
ABIOMED (ABMD) United States $8.715B 49.89
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.135B 22.91
Penumbra (PEN) United States $5.054B 181.56
Elekta AB (EKTAY) Sweden $4.932B 39.35
Globus Medical (GMED) United States $4.827B 30.64
LivaNova (LIVN) United Kingdom $3.751B 28.60
Cantel Medical (CMD) United States $3.706B 37.59
Tandem Diabetes Care (TNDM) United States $3.350B 0.00
Wright Medical Group (WMGI) Netherlands $2.662B 233.44
Nihon Kohden (NHNKY) Japan $2.529B 25.45
Nevro (NVRO) United States $2.495B 0.00
Integer Holdings (ITGR) United States $2.473B 17.49
Glaukos (GKOS) United States $2.210B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.724B 31.97
Silk Road Medical (SILK) United States $1.230B 0.00
Veracyte (VCYT) United States $1.205B 0.00
OPKO Health (OPK) United States $1.170B 0.00
Natus Medical (NTUS) United States $1.031B 24.02
Accelerate Diagnostics (AXDX) United States $0.977B 0.00
CryoLife (CRY) United States $0.974B 92.79
ORTHOFIX MEDICAL INC (OFIX) United States $0.952B 29.89
Inogen (INGN) United States $0.940B 23.05
Tactile Systems Technology (TCMD) United States $0.924B 114.19
Luminex (LMNX) United States $0.921B 0.00
Corindus Vascular Robotics (CVRS) United States $0.889B 0.00
Pacific Biosciences Of California (PACB) United States $0.857B 0.00
Mesa Laboratories (MLAB) United States $0.852B 39.38
Quotient (QTNT) Switzerland $0.714B 0.00
AngioDynamics (ANGO) United States $0.699B 22.87
AxoGen (AXGN) United States $0.573B 0.00
Intersect ENT (XENT) United States $0.503B 0.00
OrthoPediatrics (KIDS) United States $0.464B 0.00
Si-Bone (SIBN) United States $0.457B 0.00
Fluidigm (FLDM) United States $0.443B 0.00
ViewRay (VRAY) United States $0.387B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.372B 14.29
GenMark Diagnostics (GNMK) United States $0.369B 0.00
Alphatec Holdings (ATEC) United States $0.343B 0.00
Sientra (SIEN) United States $0.316B 0.00
Semler Scientific (SMLR) United States $0.312B 52.75
Accuray (ARAY) United States $0.269B 0.00
IRadimed (IRMD) United States $0.239B 39.62
CRH Medical (CRHM) Canada $0.234B 81.25
RTI Surgical (RTIX) United States $0.222B 33.33
TransEnterix (TRXC) United States $0.207B 0.00
SeaSpine Holdings (SPNE) United States $0.204B 0.00
Neuronetics (STIM) United States $0.178B 0.00
Stereotaxis (STXS) United States $0.167B 0.00
ConforMIS (CFMS) United States $0.126B 0.00
Sensus Healthcare (SRTS) United States $0.104B 0.00
Second Sight Medical Products (EYES) United States $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Ekso Bionics Holdings (EKSO) United States $0.063B 0.00
Spectral Diagnostics (EDTXF) Canada $0.062B 0.00
Helius Medical Technologies (HSDT) United States $0.052B 0.00
Vermillion (VRML) United States $0.052B 0.00
Electromed (ELMD) United States $0.044B 22.83
Xtant Medical Holdings (XTNT) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.036B 0.00
Nuvectra (NVTR) United States $0.028B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.027B 0.00
Restoration Robotics (HAIR) United States $0.026B 0.00
Ra Medical Systems (RMED) United States $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.025B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Bioanalytical Systems (BASI) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
Lianluo Smart (LLIT) China $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.83
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Dynatronics (DYNT) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00